CytomX Therapeutics (CTMX) Prepaid Assets (2014 - 2026)
CytomX Therapeutics' (CTMX) quarterly Prepaid Assets came in at $5.7 million in Q1 2026, up 20.0% YoY from $4.8 million in Q1 2025, and up 18.27% on a QoQ basis from $4.9 million in Q4 2025.
CytomX Therapeutics (CTMX) Prepaid Assets (2014 - 2026) Analysis & Trends
CytomX Therapeutics (CTMX) has 13 years of Prepaid Assets data on file, last reported at $5.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 20.0% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (up 20.0% YoY) and the FY2025 annual result came in at $4.9 million, up 35.68% from the prior year.
- Prepaid Assets climbed to $5.7 million in Q1 2026, from $4.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $7.5 million in Q4 2022 to a low of $3.1 million in Q2 2024.
- A 5-year average of $4.7 million and a median of $4.7 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 74.24% — and 2024, when it plunged 43.37%.
- Tracing CTMX's Prepaid Assets over 5 years: stood at $7.5 million in 2022, then tumbled by 33.1% to $5.0 million in 2023, then dropped by 28.35% to $3.6 million in 2024, then jumped by 35.68% to $4.9 million in 2025, then advanced by 18.27% to $5.7 million in 2026.
- The last three Prepaid Assets figures came in at $5.7 million (Q1 2026), $4.9 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.46 Mn |
| Mar 31, 2026 | 5.74 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 3.96 Mn |
| Jun 30, 2025 | 4.67 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.79 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 4.68 Mn |
| Jun 30, 2023 | 5.04 Mn |
| Mar 31, 2023 | 6.69 Mn |
| Dec 31, 2022 | 7.47 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 4.90 Mn |
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 3.82 Mn |